Avenue Therapeutics (ATXI) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-15.4
-10.08
-4.76
0.56

Details

Expected EPS
-0.94
Actual EPS
-1.92
Surprise EPS
-0.98
Surprise Percent
+104.26%

Description

Avenue Therapeutics (ATXI) has reported earnings of -1.92 per share for Q4 2024.

0 Comments

Share your thoughts